UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004355
Receipt number R000005206
Scientific Title Observational study of the treatment for low risk neuroblastomas with decision of surgical indications based on IDRF (Image Defined Risk Factors)
Date of disclosure of the study information 2010/10/21
Last modified on 2011/04/07 09:14:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational study of the treatment for low risk neuroblastomas with decision of surgical indications based on IDRF (Image Defined Risk Factors)

Acronym

Observational study of the treatment for low risk neuroblastomas based on IDRF

Scientific Title

Observational study of the treatment for low risk neuroblastomas with decision of surgical indications based on IDRF (Image Defined Risk Factors)

Scientific Title:Acronym

Observational study of the treatment for low risk neuroblastomas based on IDRF

Region

Japan


Condition

Condition

neuroblastoma

Classification by specialty

Hematology and clinical oncology Surgery in general Pediatrics
Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To observe and evaluate the incidence of adverse events such as the incidence of surgical complication, and the efficacy of the treatment for low risk neuroblastomas with decision of surgical indications based on IDRF (Image Defined Risk Factors)

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

3-year progression free survival rate
3-year overall survival rate
The incidence of surgical complication
The incidence of adverse events

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

18 years-old >

Gender

Male and Female

Key inclusion criteria

Low risk neuroblastoma patients under 18 years of age

Key exclusion criteria

Active double cancer, pregnant or possiblly pregnant women and those during breast feeding, patients with psychologic disease or symptoms who have difficulty in receiving protocol treatment, patients with disease that
may interfere with the protocol treatment

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tatsuro Tajiri

Organization

Kyushu University Hospital

Division name

Pediatric Surgery

Zip code


Address

3-1-1 Maidashi, Higashi-ku, Fukuoka city

TEL

092-542-5573

Email



Public contact

Name of contact person

1st name
Middle name
Last name Tatsuro Tajiri

Organization

Kyushu University Hospital

Division name

Pediatric Surgery

Zip code


Address

3-1-1 Maidashi, Higashi-ku, Fukuoka city

TEL

092-642-5573

Homepage URL


Email

taji@pedsurg.med.kyushu-u.ac.jp


Sponsor or person

Institute

Japan Neuroblastoma Study Group

Institute

Department

Personal name



Funding Source

Organization

A research grant from the Ministry of Health,
Labor and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 10 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2010 Year 08 Month 30 Day

Date of IRB


Anticipated trial start date

2010 Year 09 Month 01 Day

Last follow-up date

2016 Year 09 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study aims to observe and evaluate the the incidence of adverse events such as the incidence of surgical complication, and the efficacy of the treatment for low risk neuroblastomas with decision of surgical indications based on IDRF (Image Defined Risk Factors).


Management information

Registered date

2010 Year 10 Month 07 Day

Last modified on

2011 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005206


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name